Pregnant women who took the antipsychotics olanzapine or quetiapine were at higher risk of gestational diabetes than those who stopped treatment during pregnancy, according to a study published in The American Journal of Psychiatry and presented at the American Psychiatric Association’s annual meeting. Women who continued the drugs while pregnant had greater comorbidity and longer antipsychotic use.
